skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: The in vivo fate of a /sup 211/At labelled monoclonal antibody with known specificity in a murine system

Journal Article · · Int. J. Radiat. Oncol., Biol. Phys.; (United States)

A monoclonal antibody reactive against the human transferrin receptor has been labelled with the alpha and X ray emitting isotope Astatine 211. The labelling procedure does not affect the ability of the product to bind to the transferrin receptor on the human leukemic cell line HL60. Using a direct binding assay, /sup 211/At labelled antibody can be specifically inhibited from binding to its target cells by excess unlabelled antibody. Furthermore, the binding inhibition demonstrated in this system correlates to enhanced clonogenic survival of these cells, indicating that very few atoms of /sup 211/At/cell are required for cell death. Data obtained from labelled antibody injected into mice show that the labelled product in serum retains the ability to bind to HL60 cells in vitro, although tissue distributions of the injected activity implies that some of the radiolabel is lost from the protein. Despite this loss of label, preliminary experiments on the localization of labelled antibody to HL60 cells growing s/c in nude mice show that tumor tissue has a higher specific activity than all other tissues, other than blood, after 12 hours. This suggests that further work on the nature of label degradation in vivo is warranted in the context of potential therapeutic and diagnostic studies.

OSTI ID:
5173222
Journal Information:
Int. J. Radiat. Oncol., Biol. Phys.; (United States), Vol. 8:11
Country of Publication:
United States
Language:
English

Similar Records

The in vivo fate of a /sup 211/At labelled monoclonal antibody with known specificity in a murine system
Journal Article · Mon Nov 01 00:00:00 EST 1982 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:5173222

Targeted cancer cell ablation in mice by an α-particle-emitting astatine-211-labeled antibody against major histocompatibility complex class I chain-related protein A and B
Journal Article · Sat Dec 15 00:00:00 EST 2018 · Biochemical and Biophysical Research Communications · OSTI ID:5173222

Therapeutic Efficacy of Astatine-211-Labeled Trastuzumab on Radioresistant SKOV-3 Tumors in Nude Mice
Journal Article · Mon Oct 01 00:00:00 EDT 2007 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:5173222